Minerva Neurosciences, Inc. (NERV)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $2.16
- As of
Kresmion compiles this page from NERV's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Minerva Neurosciences, Inc. (NERV): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.
See the full NERV dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NERV on one page. Preview it with sample data, then open it live with a free account.
Preview the NERV dossierActive events for NERV
- mediumEarnings above estimates
Q3-2026: Beat consensus by 1630.0%, EPS $1.94 vs $-0.1268 estimate
- mediumEarnings below estimates
Q2-2026: Missed consensus by 44.9%, EPS $-0.17 vs $-0.1173 estimate
- mediumEarnings above estimates
Q2-2025: Beat consensus by 53.2% - EPS $-0.43 vs $-0.918 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 109.2% - EPS $-0.64 vs $-0.306 estimate
- mediumEarnings above estimates
Q1-2025: Beat consensus by 54.2% - EPS $-0.5 vs $-1.0914 estimate
FREE, NO ACCOUNT
Every event on NERV, as it fires
You are seeing 5 of 8 events recorded on NERV since 2026-05-31.
The five above landed across 4 days. The other 3 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
NERV positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 603380205 · 2026Q3 | $141K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NERV
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on NERV
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in NERV on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on NERV in the last 180 days.
Upstream: SEC EDGAR filings for NERV
Kresmion, "Minerva Neurosciences, Inc. (NERV) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/NERV. Upstream data: SEC EDGAR filings for NERV.
Link to this data (HTML):
<a href="https://kresmion.com/research/NERV">Minerva Neurosciences, Inc. (NERV) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow NERV on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to NERV for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.